CHPA, CRN Remind US FDA About Enforcement In Comments On NDIN Master File Draft Guidance
Executive Summary
CRN is “disappointed the draft guidance was not accompanied with an announcement by FDA of its commitment to rigorously enforce the NDI notification requirement.” CHPA says NDIN “requirement is only meaningful if FDA consistently takes enforcement action against manufacturers and distributors” noncompliant with the requirement.